Johanna Mercier

executive

Johanna Mercier is a prominent executive at Gilead Sciences, serving as the Chief Commercial and Corporate Affairs Officer. She has played a critical role in advancing the company's strategic partnerships and initiatives aimed at improving global health outcomes, particularly in the field of HIV prevention and treatment. Mercier's leadership was highlighted in a recent agreement with the Pan American Health Organization (PAHO) to expand access to lenacapavir, a long-acting HIV prevention drug, in Latin America and the Caribbean, reflecting her commitment to public health and collaborative efforts to combat the HIV epidemic.